发明名称 T-TYPE CALCIUM CHANNEL BLOCKER
摘要 It is an object to provid a novel compound that has an excellent T-type calcium channel inhibitory activity and is specifically useful for prevention or treatment of pain, chronic kidney disease and atrial fibrillation. The present invention provides a novel triazinone compound of Formula (I): where each substituent in the formula is defined in detail in the description, and R 1 means a hydrogen atom, or a C 1-6 alkyl group, etc., E means a 7 to 14-membered non-aromatic fused heterocyclic group, L 3 means a C 1-6 alkylene group, etc., D means a C 6-14 aryyl group or a 5 to 10-membered heteroaryl group each of which is optionally substituted, etc., a tautomer of the compound, or a pharmaceutically acceptable salt thereof, or a solvate thereof.
申请公布号 EP3053917(A1) 申请公布日期 2016.08.10
申请号 EP20140851204 申请日期 2014.10.02
申请人 NISSAN CHEMICAL INDUSTRIES, LTD. 发明人 NIWA, MASATOSHI;INABA, YUSUKE;IWAMOTO, TOSHIMASA;SHINTANI, YUSUKE;NAGAI, HIROSHI;EGI, JUN;ADACHI, MICHIAKI;HIRAI, YUICHI
分类号 C07D401/14;A61K31/53;A61K31/55;A61P25/04;A61P43/00;C07D401/04;C07D409/14;C07D417/14;C07D471/04;C07D487/04;C07D491/056;C07D495/04;C07D513/04 主分类号 C07D401/14
代理机构 代理人
主权项
地址